Anticancer activity of ginseng and soy saponins

Nutrition and Cancer Prevention

Volumn , Issue , 2005, Pages 457-486

  Popovich, David G ^a   Kitts, David D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057703458     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (118)

1. Estrada A, Katselis GS, Laarveld B, Barl B. Isolation and evaluation of immunological adjuvant activities of saponins from Polygala senega L. Comp Immunol Microbiol Infect Dis 2000; 23:27-43.
2. Popovich DG, Kitts DD. Bioactive properties of ginseng and ginsenosides constituents. Recent Res Dev Mol Cell Biochem 2003; 1:137-149.
3. Rao AV, Sung MK. Saponins as anticarcinogens. J Nutr 1995; 125:717S-724S.
4. Yun TK. Brief introduction of Panax ginseng C.A. Meyer. J Korean Med Sci 2001; 16 Suppl:S3-S5.
5. Tang W, Eisenbran G. Panax ginseng C.A. Meyer. In: Tang W, Eisenbrand G, eds. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine. Berlin: Springer-Verlag; 1992:710-737.
6. Shiraiwa M, Kudo S, Shimoyamada M, Harada K, Okubo K. Composition and structure of “group A saponin” in soybean seed. Agric Biol Chem 1991; 55:315-322.
7. Shiraiwa M, Harada K, Okubo K. Composition and structure of “group B saponin” in soybean seed. Agric Biol Chem 1991; 55:911-917.
8. Tava A, Mella M, Bialy Z, Jurzysta M. Stability of saponins in alcoholic solutions:ester formation as artifacts. J Agric Food Chem 2003; 51:1797-1800.
9. Sen S, Makkar HP, Becker K. Alfalfa saponins and their implication in animal nutrition. J Agric Food Chem 1998; 46:131-140.
10. Francis G, Kerem Z, Makkar HP, Becker K. The biological action of saponins in animal systems: a review. Br J Nutr 2002; 88:587-605.
11. Lee MH, Jeong JH, Seo JW et al. Enhanced triterpene and phytosterol biosynthesis in Panax ginseng overexpressing squalene synthase gene. Plant Cell Physiol 2004; 45:976-984.
12. Setzer WN, Setzer MC. Plant-derived triterpenoids as potential antineoplastic agents. Mini Rev Med Chem 2003; 3:540-556.
13. Kim WY, Kim JM, Han SB et al. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000; 63:1702-1704.
14. Popovich DG, Kitts DD. Mechanistic studies on protopanaxadiol, Rh2 and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells. J Biochem Mol Toxicol 2004; 18:143-149.
15. Popovich DG, Kitts DD. Generation of ginsenosides Rg3 and Rh2 from North American ginseng. Phytochemistry 2004; 65:337-344.
16. Attele AS, Zhou YP, Xie JT et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002; 51:1851-1858.
17. Kim YK, Guo Q, Packer L. Free radical scavenging activity of red ginseng aqueous extracts. Toxicology 2002; 172:149-156.
18. Kitts DD, Wijewickreme AN, Hu C. Antioxidant properties of a North American ginseng extract. Mol Cell Biochem 2000; 203:1-10.
19. Hu C, Kitts DD. Free radical scavenging capacity as related to antioxidant activity and ginsenoside composition of Asian and North American ginseng extracts. J Am Oil Chem Soc 2001; 78:249-255.
20. Keum YS, Park KK, Lee JM et al. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 2000; 150:41-48.
21. Kim YH, Park KH, Rho HM. Transcriptional activation of the Cu, Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 1996; 271:24539-24543.
22. Voces J, Alvarez AI, Vila L, Ferrando A, Cabral DO, Prieto JG. Effects of administration of the standardized Panax ginseng extract G115 on hepatic antioxidant function after exhaustive exercise. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999; 123:175-184.
23. Kim CS, Park JB, Kim KJ, Chang SJ, Ryoo SW, Jeon BH. Effect of Korea red ginseng on cerebral blood flow and superoxide production. Acta Pharmacol Sin 2002; 23:1152-1156.
24. Rimar S, Lee-Mengel M, Gillis CN. Pulmonary protective and vasodilator effects of a standardized Panax ginseng preparation following artificial gastric digestion. Pulm Pharmacol 1996; 9:205-209.
25. Liu ZQ, Luo XY, Liu GZ, Chen YP, Wang ZC, Sun YX. In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes. J Agric Food Chem 2003; 51:2555-2558.
26. Liu ZQ, Luo XY, Sun YX, Chen YP, Wang ZC. Can ginsenosides protect human erythrocytes against free-radical-induced hemolysis? Biochim Biophys Acta 2002; 1572:58-66.
27. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996; 22:65-72.
28. Zhou DL, Kitts DD. Peripheral blood mononuclear cell production of TNF-alpha in response to North American ginseng stimulation. Can J Physiol Pharmacol 2002; 80:1030-1033.
29. Cho JY, Yoo ES, Baik KU, Park MH, Han BH. In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists. Planta Med 2001; 67:213-218.
30. Wang H, Actor JK, Indrigo J, Olsen M, Dasgupta A. Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. Clin Chim Acta 2003; 327:123-128.
31. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997; 35:229-235.
32. Song Z, Johansen HK, Faber V et al. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother 1997; 41:961-964.
33. Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 1990; 16:537-542.
34. Wang M, Guilbert LJ, Ling L et al. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J Pharm Pharmacol 2001; 53:1515-1523.
35. Cho YK, Sung H, Lee HJ, Joo CH, Cho GJ. Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed. Int Immunopharmacol 2001; 1:1295-1305.
36. Sonoda Y, Kasahara T, Mukaida N, Shimizu N, Tomoda M, Takeda T. Stimulation of interleukin-8 production by acidic polysaccharides from the root of Panax ginseng. Immunopharmacology 1998; 38:287-294.
37. Hasegawa H, Sung JH, Benno Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med 1997; 63:436-440.
38. Bae EA, Han MJ, Choo MK, Park SY, Kim DH. Metabolism of 20(S)- and 20(R)- ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull 2002; 25:58-63.
39. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002; 25:743-747.
40. Jie YH, Cammisuli S, Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 1984; 15:386-391.
41. Park IH, Piao LZ, Kwon SW et al. Cytotoxic dammarane glycosides from processed ginseng. Chem Pharm Bull 2002; 50:538-540.
42. Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002; 406:1-8.
43. Lee SJ, Ko WG, Kim JH, Sung JH, Moon CK, Lee BH. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem Pharmacol 2000; 60:677-685.
44. Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 2000; 67:1297-1306.
45. Oh M, Choi YH, Choi S et al. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999; 14:869-875.
46. Popovich DG, Kitts DD. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines (Int-407 and Caco-2). Can J Physiol Pharmacol 2004; 82:183-190.
47. Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS, Ikejima T. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin 2002; 23:315-322.
48. Jin YH, Yoo KJ, Lee YH, Lee SK. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem 2000; 275:30256-30263.
49. Ota T, Maeda M, Odashima S, Ninomiya-Tsuji J, Tatsuka M. G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells. Life Sci 1997; 60:L39-L44.
50. Ota T, Maeda M, Odashima S. Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. J Pharm Sci 1991; 80:1141-1146.
51. Odashima S, Ohta T, Kohno H et al. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res 1985; 45:2781-2784.
52. Foulkes EC. Toxic effects on membrane structure and function. In: Foulkes EC, ed. Biological Membranes in Toxicology. Ann Arbor, MI: Taylor & Francis; 1998:59-88.
53. Lee YJ, Chung E, Lee KY, Lee YH, Huh B, Lee SK. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol 1997; 133:135-140.
54. Wehling M. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 1997; 59:365-393.
55. Falkenstein E, Norman AW, Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab 2000; 85:2072-2075.
56. Shivaji S, Jagannadham MV. Steroid-induced perturbations of membranes and its relevance to sperm acrosome reaction. Biochim Biophys Acta 1992; 1108:99-109.
57. Hostettman K. Analysis and isolation. In: Hostettmann K, Marston A, eds. Chemistry and Pharmacology of Natural Products. New York: Cambridge University Press; 1995:122-174.
58. Prokof’eva NG, Anisimov MM, Kiseleva MI, Rebachuk NM, Pokhilo ND. Cytotoxic activity of dammarane triterpenoids from birch leaves. Izv Akad Nauk Ser Biol 2002; 645-649.
59. Ma LY, Xiao PG. Effects of panax notoginseng saponins on platelet aggregation in rats with middle cerebral artery occlusion or in vitro and on lipid fluidity of platelet membrane. Phytother Res 1998; 12:138-140.
60. Kimura Y, Okuda H, Arichi S. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J Pharm Pharmacol 1988; 40:838-843.
61. Teng CM, Kuo SC, Ko FN et al. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng. Biochim Biophys Acta 1989; 990:315-320.
62. Tachikawa E, Kudo K, Nunokawa M, Kashimoto T, Takahashi E, Kitagawa S. Characterization of ginseng saponin ginsenoside-Rg(3) inhibition of catecholamine secretion in bovine adrenal chromaffin cells. Biochem Pharmacol 2001; 62:943-951.
63. Burns M, Duff K. Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer’s disease. Neurochem Res 2003; 28:979-986.
64. Clarke R, van den Berg HW, Murphy RF. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol. J Natl Cancer Inst 1990; 82:1702-1705.
65. Sung M, Kendall C, Koo M, Rao A. Effect of soybean saponins and gypsophilla saponin on growth and viability of colon carcinoma cells in culture. Nutr Cancer 1995; 23:259-269.
66. Burns CP, Luttenegger DG, Dudley DT, Buettner GR, Spector AA. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells. Cancer Res 1979; 39:1726-1732.
67. Willmer EN. Steroids and cell surface. Biol Rev 1962; 36:368-398.
68. Hasegawa H, Sung JH, Matsumiya S et al. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med 1995; 61:409-413.
69. Popov AM. Comparative study of cytotoxic and hemolytic effects of triterpenoids isolated from ginseng and sea cucumber. Izv Akad Nauk Ser Biol 2002; 155-164.
70. Keukens EA, de Vrije T, van den BC et al. Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta 1995; 1240:216-228.
71. Pastan I, Gottesman MM. Multidrug resistance. Annu Rev Med 1991; 42:277-286.
72. Molnar J, Szabo D, Pusztai R et al. Membrane associated antitumor effects of crocine-, ginseno. Anticancer Res. 2000; 20:861-867.
73. Kim SW, Kwon HY, Chi DW et al. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol 2003; 65:75-82.
74. Yun TK, Kim SH, Lee YS. Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. Anticancer Res 1995; 15:839-845.
75. Wargovich MJ. Colon cancer chemoprevention with ginseng and other botanicals. J Korean Med Sci 2001; 16:S81-S86.
76. Fukushima S, Wanibuchi H, Li W. Inhibition by ginseng of colon carcinogenesis in rats. J Korean Med Sci 2001; 16 Suppl:S75-S80.
77. Wu XG, Zhu DH, Li X. Anticarcinogenic effect of red ginseng on the development of liver cancer induced by diethylnitrosamine in rats. J Korean Med Sci 2001; 16:S61-S65.
78. Bespalov VG, Alexandrov VA, Limarenko AY et al. Chemoprevention of mammary, cervix and nervous system carcinogenesis in animals using cultured Panax ginseng drugs and preliminary clinical trials in patients with precancerous lesions of the esophagus and endometrium. J Korean Med Sci 2001; 16:S42-S53.
79. Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 1993; 120:24-26.
80. Mochizuki M, Yoo YC, Matsuzawa K et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995; 18:1197-1202.
81. Nakata H, Kikuchi Y, Tode T et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 1998; 89:733-740.
82. Yun TK, Choi SY. A case-control study of ginseng intake and cancer. Int J Epidemiol 1990; 19:871-876.
83. Yun TK, Choi SY, Yun HY. Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? J Korean Med Sci 2001; 16 Suppl:S19-S27.
84. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998; 27:359-364.
85. Suh SO, Kroh M, Kim NR, Joh YG, Cho MY. Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer. Am J Chin Med 2002; 30:483-494.
86. Anderson RL, Wolf WJ. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J Nutr 1995; 125:581S-588S.
87. Hu J, Reddy MB, Hendrich S, Murphy PA. Soyasaponin I and sapongenol B have limited absorption by Caco-2 intestinal cells and limited bioavailability in women. J Nutr 2004; 134:1867-1873.
88. Yoshikoshi M, Yoshiki Y, Okubo K, Seto J, Sasaki Y. Prevention of hydrogen peroxide damage by soybean saponins to mouse fibroblasts. Planta Med 1996; 62:252-255.
89. Yoshiki Y, Kahara T, Okubo K, Sakabe T, Yamasaki T. Superoxide- and 1,1- diphenyl-2-picrylhydrazyl radical-scavenging activities of soyasaponin beta g related to gallic acid. Biosci Biotechnol Biochem 2001; 65:2162-2165.
90. Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T, Yoshikawa M. Relationship between adjuvant activity and amphipathic structure of soyasaponins. Vaccine 2003; 21:2145-2151.
91. Nakashima H, Okubo K, Honda Y, Tamura T, Matsuda S, Yamamoto N. Inhibitory effect of glycosides like saponin from soybean on the infectivity of HIV in vitro. AIDS 1989; 3:655-658.
92. Sung MK, Kendall CW, Rao AV. Effect of soybean saponins and gypsophila saponin on morphology of colon carcinoma cells in culture. Food Chem Toxicol 1995; 33:357-366.
93. Sung MK, Kendall CW, Koo MM, Rao AV. Effect of soybean saponins and gypsophilla saponin on growth and viability of colon carcinoma cells in culture. Nutr Cancer 1995; 23:259-270.
94. Gurfinkel DM, Rao AV. Soyasaponins: the relationship between chemical structure and colon anticarcinogenic activity. Nutr Cancer 2003; 47:24-33.
95. Oh YJ, Sung MK. Soybean saponins inhibit cell proliferation by suppressing PKC activation and induce differentiation of HT-29 human colon adenocarcinoma cells. Nutr Cancer 2001; 39:132-138.
96. Kim HY, Yu R, Kim JS, Kim YK, Sung MK. Antiproliferative crude soy saponin extract modulates the expression of IkappaBalpha, protein kinase C, and cyclooxygenase-2 in human colon cancer cells. Cancer Lett 2004; 210:1-6.
97. Rowlands JC, Berhow MA, Badger TM. Estrogenic and antiproliferative properties of soy sapogenols in human breast cancer cells in vitro. Food Chem Toxicol 2002; 40:1767-1774.
98. Berhow MA, Wagner ED, Vaughn SF, Plewa MJ. Characterization and antimutagenic activity of soybean saponins. Mutat Res 2000; 448:11-22.
99. Wu CY, Hsu CC, Chen ST, Tsai YC. Soyasaponin I, a potent and specific sialyltransferase inhibitor. Biochem Biophys Res Commun 2001; 284:466-469.
100. Gurfinkel DM, Rao AV. Determination of saponins in legumes by direct densitometry. J Agric Food Chem 2002; 50:426-430.
101. Kinjo J, Imagire M, Udayama M, Arao T, Nohara T. Structure-hepatoprotective relationships study of soyasaponins I-IV having soyasapogenol B as aglycone. Planta Med 1998; 64:233-236.
102. Ikeda T, Udayama M, Okawa M, Arao T, Kinjo J, Nohara T. Partial hydrolysis of soyasaponin I and the hepatoprotective effects of the hydrolytic products. Study of the structure-hepatoprotective relationship of soyasapogenol B analogs. Chem Pharm Bull (Tokyo) 1998; 46:359-361.
103. Koratkar R, Rao AV. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr Cancer 1997; 27:206-209.
104. Park JA, Lee KY, Oh YJ, Kim KW, Lee SK. Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 1997; 121:73-81.
105. Lee KY, Park JA, Chung E, Lee YH, Kim SI, Lee SK. Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett 1996; 110:193-200.
106. Kim HE, Oh JH, Lee SK, Oh YJ. Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive ox. Life Sci 1999; 65:L33-L40.
107. Ota T, Fujikawa-yamamoto K, Zong ZP et al. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 1987; 47:3863-3867.
108. Jin YH, Yim H, Park JH, Lee SK. Cdk2 activity is associated with depolarization of mitochondrial membrane potential during apoptosis. Biochem Biophys Res Commun 2003; 305:974-980.
109. Kim SE, Lee YH, Park JH, Lee SK. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur J Cancer 1999; 35:507-511.
110. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 1998; 246:725-730.
111. Kim YS, Kim DS, Kim SI. Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Int J Biochem Cell Biol 1998; 30:327-338.
112. Park MT, Cha HJ, Jeong JW et al. Glucocorticoid receptor-induced down-regulation of MMP-9 by ginseng components, PD and PT contributes to inhibition of the invasive capacity of HT1080 human fibrosarcoma cells. Mol Cells 1999; 9:476-483.
113. Hwang SJ, Cha JY, Park SG et al. Diol- and triol-type ginseng saponins potentiate the apoptosis of NIH3T3 cells exposed to methyl methanesulfonate. Toxicol Appl Pharmacol 2002; 181:192-202.
114. Bae EA, Han MJ, Choo MK, Park SY, Kim DH. Metabolism of 20(S)- and 20(R)- ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull 2002; 25:58-63.
115. Lee Y, Jin Y, Lim W et al. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 2003; 84:463-468.
116. Byun BH, Shin I, Yoon YS, Kim SI, Joe CO. Modulation of protein kinase C activity in NIH 3T3 cells by plant glycosides from Panax ginseng. Planta Med 1997; 63:389-392.
117. Lee SJ, Sung JH, Lee SJ, Moon CK, Lee BH. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 1999; 144:39-43.
118. Kitts DD, Popovich DG. Ginseng. In: Watson D, ed. Performance Functional Foods. New York: Woodhead; 2003:78-88.